title: Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structural elucidation of the O36-antigen polysaccharide.
abstract: The O-specific polysaccharide (OPS) isolated from the lipopolysaccharide of Proteus mirabilis O36 was found to have a pentasaccharide repeating unit of the following structure: -->2)-beta-D-Ribf-(1-->4)-beta-D-Galp-(1-->4)-alpha-D-GlcpNAc6Ac-(1-->4)-beta-D-Galp-(1-->3)-alpha-D-GlcpNAc-(1-->. The structure is unique among Proteus OPS, which is in agreement with the classification of this strain into a separate Proteus O-serogroup. Remarkably, the P. mirabilis O36-polysaccharide has the same structure as the OPS of Escherichia coli O153, except that the latter is devoid of O-acetyl groups. The cross-reaction of anti-O36 antibodies with the O-part of E. coli O153 lipopolysaccharide is observed. In the present study, two steps of serotyping Proteus strains are proposed: screening of dry mass with enzyme-linked immunosorbent assay and immunoblot with the crude lipopolysaccharides. This method allowed serotyping of 99 P. mirabilis strains infecting the human urinary tract. Three strains were classified into serogroup O36. The migration pattern of these lipopolysaccharides fraction with long O-specific PSs was similar to the standard laboratory P. mirabilis O36 (Prk 62/57) lipopolysaccharide. The relatively low number of clinical strains belonging to serogroup O36 did not correspond to the presence of anti-P. mirabilis O36 antibodies in the blood donors' sera. Twenty-five percent of tested sera contained a statistically significant elevated level of antibodies reacting with thermostable surface antigens of P. mirabilis O36. The presence and amount of antibodies correlated with Thr399Ile TLR4 polymorphism types (P=0.044).
authors.affiliation: Department of Microbiology, Institute of Biology, Swietokrzyska Academy, ul. Swietokrzyska, Kielce, Poland. arabski@pu.kielce.pl
authors.forename: Michał
authors.initials: M
authors.lastname: Arabski
authors.forename: Sebastian
authors.initials: S
authors.lastname: Grabowski
authors.forename: Iwona
authors.initials: I
authors.lastname: Konieczna
authors.forename: Wiesław
authors.initials: W
authors.lastname: Kaca
authors.forename: Anna N
authors.initials: AN
authors.lastname: Kondakova
authors.forename: Andrei V
authors.initials: AV
authors.lastname: Perepelov
authors.forename: Sofya N
authors.initials: SN
authors.lastname: Senchenkova
authors.forename: Alexander S
authors.initials: AS
authors.lastname: Shashkov
authors.forename: Yuriy A
authors.initials: YA
authors.lastname: Knirel
mesh_terms: D000907:Antibodies, Bacterial / Q000378:metabolism; D002240:Carbohydrate Sequence; D003429:Cross Reactions; D004926:Escherichia coli / Q000737:chemistry; D006801:Humans; D008969:Molecular Sequence Data; D019081:O Antigens / Q000737:chemistry* / Q000276:immunology*; D011513:Proteus mirabilis / Q000737:chemistry* / Q000145:classification* / Q000302:isolation & purification; D012703:Serotyping; D014552:Urinary Tract Infections / Q000382:microbiology
chemical_list: D000907:Antibodies, Bacterial; D019081:O Antigens